News dated
On 9 September, WHO announced prequalification of the multidose presentation of Abrysvo, a maternal vaccine against respiratory syncytial virus, or RSV. [1]
The official record lists three doses per vial and an effective prequalification date of 24 August 2026: the announcement follows that assessment. [2]
The bright side
WHO expects lower costs and simpler delivery, particularly in Gavi-supported countries. These are prospects for access, not distribution results already achieved. [1]
Straight from the source.
- WHO prequalifies multi-dose RSV vaccine vial, paving the way to protecting more infants globally Organizzazione mondiale della sanità · 9 Sept 2026
- Abrysvo WHO · Prequalification of Medical Products · No publication date provided
Original reporting summaries prepared with AI assistance and accessible sources. Our editorial method.
